GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinohealth Holdings Ltd (HKSE:02361) » Definitions » Enterprise Value

Sinohealth Holdings (HKSE:02361) Enterprise Value : HK$759.6 Mil (As of May. 10, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Sinohealth Holdings Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sinohealth Holdings's Enterprise Value is HK$759.6 Mil. Sinohealth Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was HK$129.3 Mil. Therefore, Sinohealth Holdings's EV-to-EBIT ratio for today is 5.87.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Sinohealth Holdings's Enterprise Value is HK$759.6 Mil. Sinohealth Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was HK$137.9 Mil. Therefore, Sinohealth Holdings's EV-to-EBITDA ratio for today is 5.51.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Sinohealth Holdings's Enterprise Value is HK$759.6 Mil. Sinohealth Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was HK$432.5 Mil. Therefore, Sinohealth Holdings's EV-to-Revenue ratio for today is 1.76.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Sinohealth Holdings's Enterprise Value is HK$759.6 Mil. Sinohealth Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was HK$94.6 Mil. Therefore, Sinohealth Holdings's EV-to-FCF ratio for today is 8.03.


Sinohealth Holdings Enterprise Value Historical Data

The historical data trend for Sinohealth Holdings's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinohealth Holdings Enterprise Value Chart

Sinohealth Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
Get a 7-Day Free Trial - - 1,722.08 1,803.58 1,622.05

Sinohealth Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,722.08 1,460.04 1,803.58 1,531.40 1,622.05

Competitive Comparison of Sinohealth Holdings's Enterprise Value

For the Health Information Services subindustry, Sinohealth Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinohealth Holdings's Enterprise Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sinohealth Holdings's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Sinohealth Holdings's Enterprise Value falls into.


;
;

Sinohealth Holdings Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Sinohealth Holdings's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

Sinohealth Holdings's Enterprise Value for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinohealth Holdings  (HKSE:02361) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Sinohealth Holdings's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=759.612/129.322
=5.87

Sinohealth Holdings's current Enterprise Value is HK$759.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinohealth Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was HK$129.3 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Sinohealth Holdings's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=759.612/137.945
=5.51

Sinohealth Holdings's current Enterprise Value is HK$759.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinohealth Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was HK$137.9 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Sinohealth Holdings's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=759.612/432.464
=1.76

Sinohealth Holdings's current Enterprise Value is HK$759.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinohealth Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was HK$432.5 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Sinohealth Holdings's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=759.612/94.574
=8.03

Sinohealth Holdings's current Enterprise Value is HK$759.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinohealth Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was HK$94.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinohealth Holdings Enterprise Value Related Terms

Thank you for viewing the detailed overview of Sinohealth Holdings's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinohealth Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Wangjiang Second Street, Room 1111, Huangge Town, Nansha District, Guangdong Province, Guangzhou City, CHN
Sinohealth is a leading provider of Big Data and artificial intelligence-based marketing and distribution information tools, including SaaS-based customer relationship management solutions to mainland China medical product manufacturers. It sources retail data through pharmacy partnerships and provides data analysis to the pharmaceutical and corporate clients it serves. Since its establishment in 2007, its focus has been on building a strong Big Data engine and networking capabilities to assist clients in their product investments and sales and marketing strategies. It is now launching various cloud-based systems and platform solutions for its clients and expanding its SaaS products, which are expected to be the key growth driver in future.
Executives
Futu Trustee Limited 2301 Trustee
Shanghai Tianyi Assets Management Co., Ltd 2201 Interest of corporation controlled by you
Yu Rong 2201 Interest of corporation controlled by you
Tianyi (bvi) Limited 2101 Beneficial owner
Shang Hai Xuan Yu Qi Ye Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Rikan Industry Investment Limited Partnership
Wang Lifang 2201 Interest of corporation controlled by you
Wu Yushu 2201 Interest of corporation controlled by you
Wlf Investment Holdings Limited 2101 Beneficial owner
Li Hanxiong 2201 Interest of corporation controlled by you
Montesy Capital Holding Ltd 2101 Beneficial owner
Wu Meirong 2202 Interest of your spouse
Ying Lian You Xian Gong Si 2101 Beneficial owner

Sinohealth Holdings Headlines

No Headlines